| Clotrimazole |
Lozenge |
|
|
Refer to USP |
|
|
2008/10/06 |
| Clozapine |
Suspension |
II (Paddle) |
50 |
Acetate Buffer (pH 4.0) |
900 |
5, 10, 15, 20 and 30 |
2015/05/28 |
| Clozapine |
Tablet (Orally Disintegrating) |
II (Paddle |
50 RPM (12.5 mg, 25 mg and 100 mg); 75 RPM (150 mg and 200 mg) |
pH 4.5 Acetate Buffer |
900 |
5, 10, 15, 20, and 30 |
2011/06/09 |
| Clozapine |
Tablet |
|
|
Refer to USP |
|
|
2011/07/21 |
| Cobicistat |
Tablet |
II (Paddle) |
75 |
50 mM Sodium Acetate Buffer, pH 4.5 |
900 |
5, 10, 15, 20 and 30 |
2015/08/27 |
| Cobicistat (Cobi)/ Darunavir Ethanolate (Drv) |
Tablet |
Cobi: II (Paddle): Drv: II (Paddle) |
Cobi: 75; Drv:75 |
Cobi: 0.05 M Citrate Phosphate Buffer, pH 4.2; Drv: 0.05 M Sodium Phosphate Buffer, pH 3.0, 2% Tween 20 |
Cobi: 900 mL; Drv: 900 mL |
Cobi: 5, 10, 15, 20 and 30; Drv: 10, 15, 20, 30 and 45 |
2016/10/20 |
| Cobicistat/Elvitegravir/ Emtricitabine/Tenofovir Alafenamide Fumarate |
Tablet |
II (Paddle) |
100 |
0.05 M sodium citrate buffer pH 5.5 containing 2.0% w/v polysorbate 80 |
1000 |
5, 10, 15, 20 and 30 |
2016/10/20 |
| Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate |
Tablet |
II (Paddle) with sinker |
100 |
0.01 N HCl with 2% w/w Polysorbate 80 |
1000 |
5, 10, 15, 20 and 30 |
2015/06/25 |
| Cobimetinib Fumarate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Codeine Sulfate |
Tablet |
|
|
Refer to USP |
|
|
2011/09/01 |
| Colchicine |
Capsule |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Colchicine |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Colesevelam HCl |
Tablet |
|
|
Disintegration Testing as per USP <701> in various media such as simulated gastric fluid and simulated intestinal fluid. |
|
|
2010/10/28 |
| Crinecerfont |
Capsule |
I (Basket) |
100 |
Tier 1 Medium: 0.6% SDS in 0.1 N HCl Tier 2 Medium: (first 12 min: 0.1 N HCl + pepsin 750,000 units/L), after 12 min add 100 mL of 5.5% SDS in 0.1 N HCl |
|
15, 20, 30, 45 and 60 |
2026/01/28 |
| Crizotinib |
Capsule |
I (Basket) |
100 |
0.1N HCl (degassed) |
900 |
5, 10, 15, 30 and 45 |
2016/04/14 |
| Crofelemer |
Tablet (Delayed Release) |
II (Paddle) |
75 |
Acid stage: 0.1 N HCl; Buffer stage: Sodium phosphate buffer, pH 6.8 |
Acid stage: 750; Buffer stage: 1000 |
Acid stage: 2 hours; Buffer stage: : 5, 10, 20, 30 and 45 minutes |
2016/06/02 |
| Cyclobenzaprine |
Capsule (Extended Release) |
|
|
Refer to USP |
|
|
2016/10/20 |
| Cyclobenzaprine HCl |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
| Cyclobenzaprine Hydrochloride |
Tablet |
II (Paddle) |
50 |
50 mM Citrate Buffer, pH 4.0 |
100 |
5, 10, 15, 20, 30, 45 and 60 |
2026/03/25 |
| Cyclophosphamide |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |